Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

被引:241
|
作者
Bonome, T
Lee, JY
Park, DC
Radonovich, M
Pise-Masison, C
Brady, J
Gardner, GJ
Hao, K
Wong, WH
Barrett, JC
Lu, KH
Sood, AK
Gershenson, DM
Mok, SC
Birrer, MJ
机构
[1] NCI, Cell & Canc Biol Branch, Canc Res Ctr, Bethesda, MD 20892 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Lab Gynecol Oncol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
[4] Stanford Univ, Dept Stat, Stanford, CA 94305 USA
[5] Univ Texas, MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA
关键词
D O I
10.1158/0008-5472.CAN-05-2240
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Papillary serous low malignant potential (LMP) tumors are characterized by malignant features and metastatic potential yet display a benign clinical course. The role of LMP tumors in the development of invasive epithelial cancer of the ovary is not clearly defined. The aim of this study is to determine the relationships among LMP tumors and invasive ovarian cancers and identify genes contributing to their phenotypes. Affymetrix U133 Plus 2.0 microarrays (Santa Clara, CA) were used to interrogate 80 microdissected serous LMP tumors and invasive ovarian malignancies along with 10 ovarian surface epithelium (OSE) brushings. Gene expression profiles for each tumor class were used to complete unsupervised hierarchical clustering analyses and identify differentially expressed genes contributing to these associations. Unsupervised hierarchical clustering analysis revealed a distinct separation between clusters containing borderline and high-grade lesions. The majority of low-grade tumors clustered with LMP tumors. Comparing OSE with high-grade and LMP expression profiles revealed enhanced expression of genes linked to cell proliferation, chromosomal instability, and epigenetic silencing in high-grade cancers, whereas LMP tumors displayed activated p53 signaling. The expression profiles of LMP, low-grade, and high-grade papillary serous ovarian carcinomas suggest that LMP tumors are distinct from high-grade cancers; however, they are remarkably similar to low-grade cancers. Prominent expression of p53 pathway members may play an important role in the LMP tumor phenotype.
引用
收藏
页码:10602 / 10612
页数:11
相关论文
共 50 条
  • [41] Advancements in Low-Grade Serous Carcinoma of the Ovary and Peritoneum
    Grisham, Rachel N.
    Chui, M. Herman
    CURRENT ONCOLOGY REPORTS, 2022, 24 (11) : 1549 - 1555
  • [42] Evaluation of estrogen receptor expression in low-grade and high-grade astrocytomas
    Tavares, Cleciton Braga
    Sheyla Gomes-Braga, Francisca das Chagas
    Sousa, Emerson Brandao
    Borges, Umbelina Soares
    Escorcio-Dourado, Carla Solange
    da Silva-Sampaio, Joao Paulo
    da Silva, Benedito Borges
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2018, 64 (12): : 1129 - 1133
  • [43] High-grade serous carcinoma arising in a low-grade serous carcinoma and micropapillary serous borderline tumour of the ovary in a 23-year-old woman
    Quddus, M. Ruhul
    Rashid, Lanita B.
    Hansen, Katrine
    Sung, C. James
    Lawrence, W. Dwayne
    HISTOPATHOLOGY, 2009, 54 (06) : 771 - 773
  • [44] Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary
    Schmeler, K. M.
    Sun, C. C.
    Bodurka, D. C.
    Deavers, M. T.
    Coleman, R. L.
    Ramirez, P. T.
    Gershenson, D. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] Low-Grade Serous Carcinoma of the Ovary: The Current Status
    Babaier, Abdulaziz
    Mal, Hanan
    Alselwi, Waleed
    Ghatage, Prafull
    DIAGNOSTICS, 2022, 12 (02)
  • [46] HISTOLOGICALLY BENIGN OR LOW-GRADE MALIGNANT-TUMORS ADJACENT TO HIGH-GRADE OVARIAN CARCINOMAS CONTAIN MOLECULAR CHARACTERISTICS OF HIGH-GRADE CARCINOMAS
    ZHENG, JP
    WAN, MH
    ZWEIZIG, S
    VELICESCU, M
    YU, MC
    DUBEAU, L
    CANCER RESEARCH, 1993, 53 (18) : 4138 - 4142
  • [47] Low-grade malignant perineurioma of the paravertebral column, transforming into a high-grade malignancy
    Karaki, S
    Mochida, J
    Lee, YH
    Nishimura, K
    Tsutsumi, Y
    PATHOLOGY INTERNATIONAL, 1999, 49 (09) : 820 - 825
  • [48] Micropapillary serous carcinoma of the ovary - A distinctive low-grade carcinoma related to serous borderline tumors
    Burks, RT
    Sherman, ME
    Kurman, RJ
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (11) : 1319 - 1330
  • [49] Mutational Spectrum in Clinically Aggressive Low-Grade Serous Carcinoma/Serous Borderline Tumors of the Ovary
    Yoon, Ju-Yoon
    Devins, Kyle
    Ko, Emily
    Burger, Robert
    Reyes, Carolina
    Drapkin, Ronny
    Schwartz, Lauren
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1164 - 1165
  • [50] Mutational Spectrum in Clinically Aggressive Low-Grade Serous Carcinoma/Serous Borderline Tumors of the Ovary
    Yoon, Ju-Yoon
    Devins, Kyle
    Ko, Emily
    Burger, Robert
    Reyes, Carolina
    Drapkin, Ronny
    Schwartz, Lauren
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1164 - 1165